GlaxoSmithKline



Ebitda Cambiamento Data
AbbVie USD 6.92B 258M 2024-12
Alcon AG USD 463M 51M 2025-03
Almirall EUR 84.73M 39K 2024-12
Amgen USD 3.75B 42M 2025-03
argenx SE 88.7M 103.13M 2024-09
AstraZeneca USD 5.08B 182M 2025-03
Bayer EUR 3.59B 1.92B 2025-03
Biogen USD 754.8M 7.2M 2024-12
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Eli Lilly USD 4.16B 2B 2025-03
Fresenius EUR 916M 56M 2025-03
Fresenius Medical Care EUR 589M 34.68M 2025-03
Galapagos EUR -158708000 177.84M 2025-03
Genmab DKK 204M 2.03B 2025-03
Gilead Sciences USD 3.21B 651M 2024-12
GlaxoSmithKline GBP 3.14B 1.06B 2025-03
Glaxosmithkline GBP 1.69B 1.6B 2024-12
GRIFOLS EUR 405.59M 130.51M 2025-03
Hikma Pharmaceutical USD 453M 98M 2024-06
Lonza CHF 873M 107M 2024-06
Merck EUR 1.42B 203M 2024-12
Merck USD 7.74B 625M 2025-03
Novartis USD 5.19B 319M 2024-12
Novo Nordisk 42.62B 6.65B 2025-03
Orion EUR 91.5M 55.5M 2025-03
Pfizer USD 6.21B 1.5B 2025-03
Philips EUR 573M 372M 2025-03
Recordati EUR 247.79M 30.83M 2025-03
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 2.86B 2.3B 2025-03
Smith & Nephew USD 844.8M 181.8M 2024-12
UCB EUR 652M 105M 2024-06



GlaxoSmithKline - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.